Study on the Impact of Electroacupuncture Combined With Self-Acupressure on the Quality of Life of Patients With Early-Stage Breast Cancer Undergoing Chemotherapy
Recruiting · NCT06601621 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
electroacupuncture+ self-acupressuresham electroacupuncture + sham self-acupressure
What this trial is about
This randomized controlled clinical trial aims to evaluate the effect of electroacupuncture combined with self-acupressure on the quality of life of early-stage breast cancer patients receiving chemotherapy.
Who can take part
Age range
18 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Aged 18 years or older and aged 75 years or younger, inclusive. with an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2;
- Patients who have not received prior chemotherapy and are scheduled to receive at least 4 cycles of adjuvant or neoadjuvant chemotherapy or combination targeted therapy;
- Normal organ function with platelets ≥ 100\*10\^9/ L, hemoglobin ≥ 90 g/L, serum creatinine ≤ 1.5 mg/dl (133 mmol/L), or creatinine clearance ≥ 60 ml/min, total bilirubin ≤ 1.5 times the upper limit of normal (ULN), alanine aminotransferase ≤ 2.5 times ULN, and aspartate aminotransferase ≤ 2.5 times ULN;
- Premenopausal women need appropriate contraception;
- Ability to understand the study well and complete the study questionnaire.
Exclusion criteria
- Patients with needle phobia or allergy to stainless steel needles; and
- Current diagnosis of mental illness (e.g., major depression, obsessive-compulsive disorder, or schizophrenia);
- History of autoimmune diseases, blood disorders, or organ transplantation, or long-term use of hormones or immunosuppressants;
- Comorbid bleeding disorders or thyroid dysfunction;
- Implantation of a pacemaker; pregnancy or breastfeeding;
- A plan for adjuvant radiotherapy in the upcoming chemotherapy cycle;
- Current active infection;
- Acupuncture treatment within the last four weeks;
- Patients who are allergic to the drugs used;
- Use of other Traditional Chinese Medicine (TCM) techniques such as Chinese herbs in the next chemotherapy cycle.
Where it is running
1 location listed.
- Qinghai University Affiliated Hospital - Xining, Qinghai, China